Sarcoidosis is a rare and chronic inflammatory condition, in which clumps of immune cells called granulomas build in one or more organs. These granulomas can prevent organs from working as they should, and may cause permanent damage. The lungs are most commonly affected organ, with some 90 percent…

Last updated June 20, 2022, by Lindsey Shapiro, PhD ✅ Fact-checked by José Lopes, PhD What is efzofitimod for sarcoidosis? Efzofitimod (formerly known as ATYR1923) is a first-in-class immunomodulatory therapy, designed to resolve inflammation and prevent subsequent scarring (fibrosis), that’s being investigated for people with…

COVID-19, short for coronavirus disease 2019, is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly identified and highly contagious pathogen not previously seen in humans. Though it belongs to the same category of viruses as SARS and influenza…

Sarcoidosis is an inflammatory condition where the immune system mistakenly attacks the body’s own tissues. Immune cell clusters known as granulomas accumulate in organs and tissues. Most cases are short-term or mild, but long-term chronic cases can cause serious organ damage. Because sarcoidosis often responds to treatment…

Sarcoidosis is a disease that is mainly diagnosed in adults from the ages of 20-40. It is characterized by the formation of clumps of immune cells called granulomas in different tissues and organs throughout the body. Childhood sarcoidosis is extremely rare and its true prevalence is unknown. A…